Clinical Trial Update: hUC-MSC-Exo Therapy for Autoimmune Encephalitis [Phase 1, Phase 2]

View source ↗

Summary

Update on a planned Phase 1/2 clinical trial evaluating hUC-MSC-Exo therapy for autoimmune encephalitis, which is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis

Drugs mentioned

• hUC-MSC-Exo therapy (human umbilical cord mesenchymal stem cell-derived exosomes)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Autoimmune Encephalitis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING